XENE

MKT CAP:$5B

Xenon Pharmaceuticals Inc

Market Cap

$5B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$51.21+$6.72 (+15.10%)

Jun 8, 2026

52W High $62.7652W Low $30.30

Company Details

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders. Its product candidates include ...

CEO

—

IPO Date

Nov 5, 2014

Website

www.xenon-pharma.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$383M

EPS (Diluted)

Free Cash Flow

-$307M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q2 2026

Aug 10, 2026

PENDING

Q1 2026

May 7, 2026

$0-100.0%

FY 2025

Feb 26, 2026

$8M

Q4 2025

Feb 26, 2026

$0-100.0%

Q3 2025

Nov 3, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee